LivaNova PLC

LIVN ·Healthcare, Medical Devices
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013
Revenue $1.01B $964.9M $291.6M $282.0M $254.3M
Cost of Revenue $353.2M $367.8M $27.3M $27.4M $21.9M
Gross Profit $651.6M $559.5M $264.2M $254.7M $232.4M
Gross Margin 64.4% 58.0% 90.6% 90.3% 91.4%
Operating Expenses
Research & Development $109.5M $82.1M $42.2M $45.2M $41.6M
SG&A Expense $380.1M $355.2M $123.6M $120.6M $112.5M
Operating Income $96.5M $33.4M $88.7M $80.0M $78.3M
Operating Margin 9.5% 3.5% 30.4% 28.4% 30.8%
Interest Expense $7.8M $10.6M $21.0K $20.0K $119.0K
Pretax Income $121.1M $25.7M $89.3M $79.9M $75.3M
Income Tax Expense $50.0M $5.1M $31.4M $25.0M $28.9M
Net Income $-25.1M $-62.8M $57.8M $54.9M $46.4M
Net Margin -2.5% -6.5% 19.8% 19.5% 18.2%
EPS (Basic) $-0.52 $-1.29 $2.19 $2.02 $1.68
EPS (Diluted) $-0.52 $-1.28 $2.17 $2.00 $1.66
Shares Outstanding (Basic) 48.2M 48.9M 26.4M 27.1M 27.6M
Shares Outstanding (Diluted) 48.5M 49.0M 26.6M 27.5M 28.0M
Dividends Per Share
← Newer Page 2 of 2 Older →